RecruitingNot Applicable

Hospital Airway Resuscitation Trial

United States1,060 participantsStarted 2023-02-10

Plain-language summary

The Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Adult aged \>=18 years
. Admitted to the hospital for any condition
. Suffered in-hospital cardiac arrest (loss of pulse and ≥2 minutes of chest compressions)
. Need for assisted ventilation (defined by initiation of bag-mask-ventilation or other supported ventilation)

Exclusion criteria

. Cardiac arrest in the Operating Room or other area not responded to by Critical Care/Emergency Department (ED) teams.
. Cardiac arrest in which an invasive airway (i.e. endotracheal tube, tracheostomy tube) is already in place
. Patients with Do Not Resuscitate or Do Not Intubate orders

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Alive-and-ventilator free days

Timeframe: From cardiac arrest until 28-days after cardiac arrest

Trial details

NCT IDNCT05520762

SponsorMontefiore Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01

Contact for this trial

Ari Moskowitz, MD

718-920-5440 amoskowitz@montefiore.org

View on ClinicalTrials.gov More Cardiac Arrest trials